跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BETAHISTINE-WGR betahistine dihydrochloride 16mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
BETAHISTINE-WGR betahistine dihydrochloride 16mg tablet blister pack
Approved
STANDARD
BETAHISTINE-WGR betahistine dihydrochloride 16mg tablet blister pack
Southern Cross Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
8357d0e2d855f335
Company
Southern Cross Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
8357d0e2d855f335
Product Name
BETAHISTINE-WGR betahistine dihydrochloride 16mg tablet blister pack
Artg Id
504366
Artg Name
BETAHISTINE-WGR betahistine dihydrochloride 16mg tablet blister pack
Sponsor
Southern Cross Pharma Pty Ltd
Company Detail Path
/organization/southern-cross-pharma-pty-ltd
Artg Date
2025-09-25
Registration Type
Medicine
Therapeutic Good Type
Medicines
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
8357d0e2d855f335
Type
Standard
Back to TGA Approvals